Skip to content

Factors causing decreased urine output during anesthesia and surgery

Anesthesia Induced Hormonal Oliguria Trial - ANIMAL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2017-001646-10-SE
Enrollment
40
Registered
2017-05-29
Start date
2017-06-22
Completion date
Unknown
Last updated
2020-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia in adult patients undergoing general surgery

Interventions

Pharmaceutical Form: Infusion INN or Proposed INN: PROPOFOL CAS Number: 2078-54-8 Other descriptive name: PROPOFOL Concentration unit: mg/ml milligram(s)/millilitre Concentration type: range Concentra

Sponsors

Uppsala University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: • Patients scheduled for major elective surgery, i.e. surgery assumed to require more than 1 hour of maintenance of general anesthesia • Scheduled to receive mechanical ventilation via tracheal intubation or laryngeal mask • Age at least 18 years • Willingness and ability to give informed consent, to understand, participate and comply with all study requirements Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 40 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: American association of anaesthesiolgy class >3 Known allergy for any of the anaesthetic agents

Design outcomes

Primary

MeasureTime frame
Main Objective: To investigate changes in renal function during general anaesthesia.;Secondary Objective: To describe changes in hormonal systems regulating fluid and electrolyte homeostasis during anesthesia Compare sevoflurane and propofol with regards to changes in renal physiology;Primary end point(s): Urine output Creatinine-clearance;Timepoint(s) of evaluation of this end point: During surgery During a two-hour post-operative period During a two-hour period the day after surgery

Secondary

MeasureTime frame
Secondary end point(s): Hormones regulating fluid and electrolyte homeostasis -Plasma arginine vasopressin -Plasma angiotensin II -Plasma aldosteron Renal function -Free water clearance -Urine soidum excretion -Urine potassium excretion;Timepoint(s) of evaluation of this end point: During surgery During a two-hour post-operative period During the day after surgery

Countries

Sweden

Contacts

Public ContactUppsala University Hospital

Uppsala University Hospital

suzanne.odeberg.wernerman@akademiska.se46186119209

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 12, 2026